The persistence of humoral and cellular immunities more than three decades after smallpox vaccination  S.-H. Kim, S.-G. Yeo, K.-H. Park, J.-W. Bang, H.-B.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Vaccines for the elderly
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
P. Dabir, S. Dabir, K.N. Krithika, K. Goswami, M.V.R. Reddy 
L. Boyanova  Clinical Microbiology and Infection 
Gut bacterial microbiota and obesity
Varicella vaccination: a laboured take-off
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
Migrant health—a cause for concern?
Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era  T.I. Pedersen, M. Howitz, C. Østergaard  Clinical.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
A serosurvey of Orientia tsutsugamushi from patients with scrub typhus
Virological tools to diagnose and monitor hepatitis C virus infection
R. Cantón  Clinical Microbiology and Infection 
P. Nordmann, L. Poirel  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Prevalence of Toscana virus antibodies in residents of Croatia
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
M. De Fost, W. Chierakul, R. Limpaiboon, A. Dondorp, N. J. White, T
Vector control: a cornerstone in the malaria elimination campaign
Cellular immune responses to recurring influenza strains have limited boosting ability and limited cross-reactivity to other strains  Y. Keynan, C.M.
Training for the infectious diseases speciality in Norway
Rickettsia prowazekii infection of endothelial cells increases leukocyte adhesion through αvβ3 integrin engagement  Y. Bechah, C. Capo, G. Grau, D. Raoult,
Rotavirus vaccination: a concise review
T-cell responses against tuberculin and sensitin in children with tuberculosis and non- tuberculosis mycobacterial lymphadenopathy  K. Magdorf, S.D. Schuck,
R. Karakus, K. Caglar, C. Aybay  Clinical Microbiology and Infection 
B. Gordts  Clinical Microbiology and Infection 
CMI editorial report 2011 Clinical Microbiology and Infection
Hepatitis C virus and interferon type III (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response.
Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes  S. Ladhani,
Clinical and microbiological characteristics of Nocardiosis including those caused by emerging Nocardia species in Taiwan, 1998–2008  C.-K. Tan, C.-C.
H. Völzke, K. M. Kloker, A. Kramer, L. Guertler, M. Dören, S. E
Elements of design: the knowledge on which we build
Levofloxacin in the treatment of ventilator-associated pneumonia
G. Pappas  Clinical Microbiology and Infection 
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
A case of pleurisy associated with antibodies to Rickettsia conorii
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
J. Garau  Clinical Microbiology and Infection 
T.M. File  Clinical Microbiology and Infection 
Antibacterial drug discovery in the 21st century
Abstracts cont. Clinical Microbiology and Infection
Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection  R. Nir-Paz, A. Michael-Gayego, M. Ron, C.
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida 
Antimicrobial drug development – the past, the present, and the future
Vaccines for the elderly
Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia  M.-S. Hsu,
An after-hours clinical liaison blood culture service—is it worth it?
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Listeriosis: a resurgent foodborne infection
Overview of cefixime use in community-acquired infections
Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study  D. Goletti, S. Carrara,
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
B. Govan, N. Ketheesan  Clinical Microbiology and Infection 
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
S.-H. Kung, S.-F. Wang, C.-W. Huang, C.-C. Hsu, H.-F. Liu, J.-Y. Yang 
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

The persistence of humoral and cellular immunities more than three decades after smallpox vaccination  S.-H. Kim, S.-G. Yeo, K.-H. Park, J.-W. Bang, H.-B. Kim, N.-J. Kim, Y. Jee, H. Cho, M.-D. Oh, K-W. Choe  Clinical Microbiology and Infection  Volume 13, Issue 1, Pages 91-93 (January 2007) DOI: 10.1111/j.1469-0691.2006.01576.x Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 (a) Neutralising antibody titres and (b) vaccinia-specific interferon (IFN)-γ-producing effector-memory responses, grouped according to the length of time since smallpox vaccination. The geometric mean titre (a) or mean (b) is represented by the horizontal lines. Line brackets indicate differences between two groups (Mann–Whitney U-test). Neutralising antibody titres or vaccinia-specific IFN-γ-producing effector-memory responses between periods since smallpox vaccination had p values of 0.01 and 0.85, respectively (Kruskal–Wallis analysis of variance) for the entire distribution. SFC, spot-forming cells; PBMC, peripheral blood mononuclear cells. Clinical Microbiology and Infection 2007 13, 91-93DOI: (10.1111/j.1469-0691.2006.01576.x) Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions